ClinConnect ClinConnect Logo
Search / Trial NCT06653491

Immediate Effects of the HVLA Talocrural Distraction Technique in Soccer Players

Launched by UNIVERSIDAD COMPLUTENSE DE MADRID · Oct 20, 2024

Trial Information

Current as of August 02, 2025

Not yet recruiting

Keywords

Ankle Manual Therapy Plantar Pressure Center Mobility

ClinConnect Summary

This clinical trial is looking at a specific physiotherapy technique called the High-Velocity Low-Amplitude (HVLA) Talocrural Distraction Technique, which is applied to the ankle. The goal of the study is to see how this technique affects amateur soccer players, particularly those who may have experienced ankle injuries. The trial is not yet recruiting participants but is targeting male soccer players aged 18 and older who have played soccer regularly, whether as amateurs or professionals.

To be eligible for the trial, participants must not have any recent injuries or conditions that would prevent them from safely undergoing the HVLA technique. This means they should not have serious leg injuries, infections, or any medical hardware in their joints. Participants will be asked to complete questionnaires and physical tests to evaluate the effects of the treatment. It's important to note that those with certain medical conditions or those who are under 18 years old will not be able to participate. This study could help improve understanding of how specific physiotherapy techniques can support recovery from ankle injuries in soccer players.

Gender

MALE

Eligibility criteria

  • Inclusion Criteria:
  • Men over 18 years old
  • Men that played or have played soccer as an amateur or professional on a regular basis
  • No previous musculoskeletal history that would contraindicate HLVA techniques (recent fractures, osteosynthesis material placed in the joint, infections...)
  • Exclusion Criteria:
  • Subjects under 18 years old
  • Subjects who have suffered musculoskeletal pathology in the lower limb that contraindicates manipulation or who have a medical diagnosis of chronic ankle instability
  • Subjects who suffer neurological or cognitive alterations that prevent the understanding of questionnaires or physical tests; and those who have not signed the informed consent documents

About Universidad Complutense De Madrid

The Universidad Complutense de Madrid (UCM) is a prestigious academic institution renowned for its commitment to research and innovation in various fields, including health sciences. As a prominent sponsor of clinical trials, UCM leverages its extensive resources and expertise to advance medical knowledge and improve patient outcomes. The university fosters collaboration among researchers, clinicians, and industry partners, ensuring the highest standards of ethics and scientific rigor in its clinical research initiatives. UCM's dedication to education and research excellence positions it as a leader in the development of new therapeutic interventions and health solutions.

Locations

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported